Status
Conditions
Treatments
About
to compare the respiratory complications in patient managed with high velocity nasal insufflation versus patients managed with conventional low flow oxygen in patients with severe chest trauma
Full description
High -velocity nasal insufflation (HVNI ) was first developed for neonates and has gained increasing use in adult patients for prevention and treatment of respiratory failure. High-flow humidified oxygen with flow rates from 30 to100 L/min with high fraction of inspired oxygen( FiO2) is able to be delivered. Positive end-expiratory pressure can be generated, preventing alveoli collapse. The washout of carbon dioxide (CO2)and replacement with enriched O2 purportedly decreases work of breathing and increases breathing effectiveness.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Chest trauma patients with lung injury confirmed by ct imaging
Exclusion criteria
• Patients < 15years old
Primary purpose
Allocation
Interventional model
Masking
86 participants in 2 patient groups
Loading...
Central trial contact
Ahmed Mandour, Consultant; Mohamed Yasser, Bachelor's
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal